# Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

> **NCT01207297** · PHASE1 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 40 (actual)

## Conditions studied

- SLE
- Lupus Nephritis
- Renal Insufficiency
- End-stage Renal Disease

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT01207297
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207297, "Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01207297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*